1096 studies found for:    (psychotic disorders OR schizophrenia) AND (woman OR women OR female)
Show Display Options
Rank Status Study
1 Completed Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
Condition: Negative Symptoms of Schizophrenia in Post-menopausal Women.
Interventions: Drug: Raloxifene;   Drug: Lactosa (placebo arm)
2 Completed Clinical Estradiol Trial in Women With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Intervention: Drug: Estradiol
3 Recruiting Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Raloxifene hydrochloride;   Drug: Placebo
4 Completed Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia
Conditions: Obesity;   Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Naltrexone 25mg;   Other: Placebo
5 Completed Homeopathic Medication and Nutritional Oriented Diet to Treat Overweight Pregnant Women With Mental Disorder
Conditions: Overweight;   Pregnancy;   Mental Disorder
Interventions: Drug: Sulph, Puls, Lyc, Lack t, Con, Sep, Nux v, Calc c, Phos;   Drug: Homeopathy and Nutritional oriented diet
6 Terminated Quality of Life (QOL) in Female Patient With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Quetiapine, Risperidone
7 Completed Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women
Condition: Schizophrenia
Intervention: Drug: raloxifene
8 Recruiting Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
Condition: Hyperprolactinemia
Interventions: Drug: Aripiprazole;   Drug: Placebo
9 Completed Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo;   Drug: SEP-363856 Open Label
10 Completed A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Placebo
11 Completed
Has Results
A Definitive Estrogen Patch Study (ADEPT)
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder(Not in Manic Phase)
Interventions: Drug: Estradiol;   Other: placebo
12 Completed Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness
Conditions: Schizophrenia;   Bipolar Disorder;   Schizoaffective Disorder
Intervention: Behavioral: Genetic Counseling
13 Completed Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects
Condition: Schizophrenia
Intervention: Drug: GSK1144814
14 Completed Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
Condition: Schizophrenia
Interventions: Drug: SEP-363856;   Drug: Amisulpride;   Drug: Placebo
15 Completed The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in Women
Conditions: Post-Traumatic Stress Disorder;   Mental Disorders;   Depression
Interventions: Behavioral: Trauma Recovery and Empowerment Model (TREM);   Behavioral: Usual care
16 Completed Clinical Study Of Schizophrenia in Both Men and Women
Condition: Schizophrenia
Intervention: Drug: lamotrigine
17 Not yet recruiting Keeping Well:Online Cognitive Behavioral Therapy (CBT) for Pregnant Women With Depressive Symptoms
Conditions: Anxiety;   Mental Disorders;   Postpartum Depression;   Depressive Symptoms
Interventions: Behavioral: Online Cognitive Behavioral Therapy (CBT);   Other: Treatment as usual
18 Recruiting Omega-3 Dietary Supplements in Schizophrenia
Conditions: Schizophrenia;   Schizophreniform Disorder;   Schizoaffective Disorder;   Bipolar I
Interventions: Drug: Risperidone;   Drug: Omega-3 capsules;   Drug: Amber 50/50 Soybean/Corn Placebo
19 Withdrawn Glycine and D-Cycloserine in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: D-cycloserine;   Drug: Glycine;   Drug: Clozapine;   Drug: Placebo
20 Completed Treatment for First-Episode Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Olanzapine;   Drug: Risperidone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years